These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23352458)

  • 21. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.
    Butt AA; Kanwal F
    Clin Infect Dis; 2012 Jan; 54(1):96-104. PubMed ID: 22156853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanding access to treatment for HIV/HCV coinfected patients.
    HRSA Careaction; 2006 Aug; ():1-12. PubMed ID: 16969925
    [No Abstract]   [Full Text] [Related]  

  • 23. New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals.
    Seden K; Back D; Khoo S
    J Antimicrob Chemother; 2010 Jun; 65(6):1079-85. PubMed ID: 20335191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current challenges in hepatitis C.
    Swan T
    Res Initiat Treat Action; 2004; 10(2):17-20. PubMed ID: 15828096
    [No Abstract]   [Full Text] [Related]  

  • 25. [HIV and hepatitis coinfection].
    Ingiliz P; Rockstroh JK
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S216-8. PubMed ID: 16435714
    [No Abstract]   [Full Text] [Related]  

  • 26. Current world literature.
    Curr Opin HIV AIDS; 2011 Nov; 6(6):566-70. PubMed ID: 21996925
    [No Abstract]   [Full Text] [Related]  

  • 27. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Coinfection with hepatitis C virus and HIV].
    Ruys TA; Reesink HW; Lange JM
    Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2056-60. PubMed ID: 14606352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future of hepatitis C therapy: development of direct-acting antivirals.
    Dore GJ; Matthews GV; Rockstroh J
    Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatic transplantation in HIV-HCV co-infected patients].
    Gadano A; Aziz H; Macias S; Villamil F
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S70-3; discussion S74-82. PubMed ID: 16862868
    [No Abstract]   [Full Text] [Related]  

  • 31. [New treatments for hepatitis C, which targets, what timeline?].
    Goossens N; Negro F
    Rev Med Suisse; 2011 Sep; 7(307):1683-8. PubMed ID: 21987876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excitement grows for potential revolution in hepatitis C virus treatment.
    Opar A
    Nat Rev Drug Discov; 2010 Jul; 9(7):501-3. PubMed ID: 20592732
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis C in 2012.
    Lemon M
    S D Med; 2012 Nov; 65(11):432-3. PubMed ID: 23189411
    [No Abstract]   [Full Text] [Related]  

  • 34. [ANRS-fibrovic and homavic: role of non invasive markers of liver fibrosis and insulin resistance during antiviral treatment in HIV-HCV co-infected patients from ANRS HC 02 RIVABIC trial].
    Halfon P; Pénaranda G; Cacoub P
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S113-7. PubMed ID: 19375039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hepatitis C virus/HIV coinfection.
    Chun S; Sherman KE
    Clin Liver Dis; 2005 Aug; 9(3):525-33, ix. PubMed ID: 16023981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor for treatment of chronic hepatitis C infections.
    Venkatraman S
    Trends Pharmacol Sci; 2012 May; 33(5):289-94. PubMed ID: 22521415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection].
    Bani-Sadr F
    Gastroenterol Clin Biol; 2003 May; 27(5):528-33. PubMed ID: 12843917
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of hepatitis C in the setting of liver transplantation.
    Khalid SK; Crippin JS
    Clin Liver Dis; 2006 May; 10(2):321-37, ix. PubMed ID: 16971264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in HIV care, Part 2: antiretrovirals in the pipeline, HIV/hepatitis C virus coinfection, and pharmacokinetics of treatment adherence--a roundtable discussion.
    Corales RB; Djeloski DS; Mancenido MD; Valenti WM
    AIDS Read; 2009 Feb; 19(2):62-4, 70-4, 78. PubMed ID: 19271330
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.
    Walsh N; Maher L
    Curr Opin HIV AIDS; 2012 Jul; 7(4):339-44. PubMed ID: 22498482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.